ClassID:

116962

C12Y304/22055 - CPC Classification

Classification description:

Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Cysteine endopeptidases (3.4.22) Caspase-2 (3.4.22.55)

Recent Application in this class:
#1
20230357436
2023-11-09

ANTI-IDIOTYPE COMPOSITIONS AND METHODS OF USE THEREOF

#2
20220380739
2022-12-01

CASPASE-2 VARIANTS

#3
20220220529
2022-07-14

Method of screening inhibitor of caspase activity by lipopolysaccharide

#4
20190351003
2019-11-21

METHODS FOR INHIBITING NONALCOHOLIC STEATOHEPATITIS, NONALCOHOLIC FATTY LIVER DISEASE, AND/OR DE NOVO LIPOGENESIS

#5
20170360048
2017-12-21

Methods and compositions for nucleic acid integration

#6
20170226519
2017-08-10

METHODS OF TREATING ISCHEMIA-REPERFUSION INJURY WITH siRNAS

#7
20160362695
2016-12-15

Methods and compositions for neuroprotection

#8
20160304879
2016-10-20

Double-stranded RNA compounds to CASP2 and uses thereof

#9
20150031746
2015-01-29

Methods and compositions for neuroprotection

#10
20140371439
2014-12-18

Double-stranded RNA compounds to CASP2 and uses thereof

#11
20140004541
2014-01-02

Method for the determination of botulinum neurotoxin biological activity

#12
20120329721
2012-12-27

MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS

#13
20120196892
2012-08-02

NOVEL CASPASE-2 INHIBITORS

#14
20110251260
2011-10-13

NOVEL siRNAS AND METHODS OF USE THEREOF

#15
20100113369
2010-05-06

MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS

#16
20090162365
2009-06-25

Novel siRNAS and methods of use thereof

#17
20090156524
2009-06-18

Novel siRNAS and methods of use thereof

#18
20070026076
2007-02-01

Molecular vaccines employing nucleic acid encoding anti-apoptotic proteins

#19
20060241034
2006-10-26

Means for preventing and treating cellular death and their biological applications